<DOC>
<DOCNO>EP-0641560</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Veterinary tablet especially meant for cats
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K900	A61K920	A61K920	A61K900	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61K	A61K	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K9	A61K9	A61K9	A61K9	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
Veterinary tablet which makes it easier for medicinal substances to be taken by domestic animals, and especially by cats, which tablet is oblong in shape and completely lacking in rotational symmetry. 
<
IMAGE
>
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
SO GE VAL SA
</APPLICANT-NAME>
<APPLICANT-NAME>
SO.GE.VAL S.A.
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
DAOUDAL JOSE
</INVENTOR-NAME>
<INVENTOR-NAME>
DAOUDAL, JOSE
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
Use of an oblong shape totally devoid of 
rotational symmetry for forming a veterinary 

tablet for facilitating the absorption of 
medicinal substances by domestic animals and 

especially cats. 
Use according to Claim 1, characterised 
in that the tablet comprises two identical oval 

principal faces (1) which are separated by a 
lateral cylindrical surface (2), the generatrix 

(x-x') of which is perpendicular to the principal 
faces (1). 
Use according to claim 2, characterised 
in that the principal faces (1) bulge outwards. 
Use according to either Claim 2 or Claim 
3, characterised in that the tablet comprises a 

narrowed region (3) at its central portion. 
Use according to any one of Claims 2 to 
4, characterised in that at least one of the 

principal faces (1) comprises at its central 
portion a notch (4) acting as a dividing groove 

for the tablet.  
 
Use according to any one of Claims 2 to 
5, characterised in that the principal faces (1) 

have a length (L) of from 6 to 15 mm and a maximum 
width (l₁) of from 4 to 6 mm. 
Use according to Claims 4 and 6, 
characterised in that the principal faces (1) have 

a width (l₂) of from 3.5 to 5.5 mm at the narrowed 
region (3). 
Use according to any one of Claims 1 to 
7, characterised in that the tablet has an average 

weight of from 120 to 200 mg. 
Use according to any one of Claims 1 to 
8, characterised in that the tablet comprises one 

or more active ingredients incorporated or 
included in an appetence-inducing matrix 

containing, especially, a mixture of liver powder 
and brewers' yeast or a mixture of various protein 

substances of animal and/or vegetable origin. 
Use according to any one of Claims 1 to 
9, characterised in that the tablet comprises 

amoxicillin, especially in trihydrated form, as 
the active ingredient. 
</CLAIMS>
</TEXT>
</DOC>
